---
figid: PMC3759013__nihms501856f1
figlink: /pmc/articles/PMC3759013/figure/F1/
number: Figure 1
caption: Activation of the receptor tyrosine kinase (RTK)-NRAS-BRAF-MEK-ERK signaling
  stream is central in a large proportion of melanomas (mels), with BRAF and NRAS
  being the most commonly activated oncogenes. Upstream of RAS, KIT is amplified or
  activated in a substantial fraction of melanomas from acral, mucosal (muc), and
  chronic sun-damaged (CSD) sites. Stimulation of the phosphatidylinositol 3-kinase
  (PI3K) pathway also occurs in melanomas either through loss of PTEN or activation
  of AKT3. In addition, GNAQ and GNA11, which encode G-α proteins, are preferentially
  mutated in ocular melanomas. Downstream effectors of the activated signaling network
  lead to increased transcription of survival genes by transcription factors and heightened
  prosurvival signals in the mitochondria (Mito) via regulation of apoptotic proteins
  (red, proapoptotic; green, prosurvival). In the nucleus, epigenetic silencing of
  tumor suppressor genes occurs through DNA methylation and/or histone acetylation,
  which are mediated by DNA methyltransferase (DNMT) and histone deactylase (HDAC),
  respectively. Targeted agents listed in the light purple boxes inhibit the central
  pathogenetic pathways at specific points of action and potentially have a therapeutic
  impact on melanoma. Ac, acetylation (of Histone, Hi); cut, cutaneous; Me, methylation
  (of DNA); TF, transcription factor.
pmcid: PMC3759013
papertitle: 'Melanoma: New Insights and New Therapies.'
reftext: Vasiliki A. Nikolaou, et al. J Invest Dermatol. 2012 Mar;132(3 0 2):854-863.
pmc_ranked_result_index: '158877'
pathway_score: 0.9689527
filename: nihms501856f1.jpg
figtitle: 'Melanoma: New Insights and New Therapies'
year: '2012'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3759013__nihms501856f1.html
  '@type': Dataset
  description: Activation of the receptor tyrosine kinase (RTK)-NRAS-BRAF-MEK-ERK
    signaling stream is central in a large proportion of melanomas (mels), with BRAF
    and NRAS being the most commonly activated oncogenes. Upstream of RAS, KIT is
    amplified or activated in a substantial fraction of melanomas from acral, mucosal
    (muc), and chronic sun-damaged (CSD) sites. Stimulation of the phosphatidylinositol
    3-kinase (PI3K) pathway also occurs in melanomas either through loss of PTEN or
    activation of AKT3. In addition, GNAQ and GNA11, which encode G-α proteins, are
    preferentially mutated in ocular melanomas. Downstream effectors of the activated
    signaling network lead to increased transcription of survival genes by transcription
    factors and heightened prosurvival signals in the mitochondria (Mito) via regulation
    of apoptotic proteins (red, proapoptotic; green, prosurvival). In the nucleus,
    epigenetic silencing of tumor suppressor genes occurs through DNA methylation
    and/or histone acetylation, which are mediated by DNA methyltransferase (DNMT)
    and histone deactylase (HDAC), respectively. Targeted agents listed in the light
    purple boxes inhibit the central pathogenetic pathways at specific points of action
    and potentially have a therapeutic impact on melanoma. Ac, acetylation (of Histone,
    Hi); cut, cutaneous; Me, methylation (of DNA); TF, transcription factor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK3
  - PIK3R6
  - CSAD
  - SIRT4
  - RAB8A
  - DNMT1
  - PIK3CA
  - SIRT5
  - MAP2K2
  - ADCY3
  - PIK3R5
  - PIK3R4
  - HDAC1
  - SIRT2
  - MAP2K1
  - MAPK1
  - CUX1
  - PIK3CD
  - ADCY2
  - SIRT1
  - MTOR
  - HDAC5
  - ADCY9
  - HDAC11
  - PTEN
  - NRAS
  - HRAS
  - KRAS
  - BRAF
  - ADCY1
  - KIT
  - PIK3CB
  - HDAC10
  - ADCY5
  - ADCY7
  - SIRT3
  - PIK3CG
  - AKT3
  - GNAQ
  - HDAC8
  - HDAC3
  - BCL2
  - HDAC4
  - ADCY6
  - ADCY8
  - SIRT7
  - PIK3R3
  - AKT2
  - AKT1
  - HDAC6
  - HDAC7
  - ADCY10
  - HDAC2
  - ADCY4
  - SIRT6
  - HDAC9
  - Lonafarnib
  - Temsirolimus
  - Nilotinib
  - AZD6244
  - RO4987655
  - GSK2118436
  - GDC-0973
  - RO5126766
  - AZD8330
  - Rapamycin
  - Cancer
  - Lung cancer
genes:
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: CSD
  symbol: CSD
  source: hgnc_alias_symbol
  hgnc_symbol: CSAD
  entrez: '51380'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT4
  entrez: '23409'
- word: mels
  symbol: MEL
  source: hgnc_prev_symbol
  hgnc_symbol: RAB8A
  entrez: '4218'
- word: DNMT
  symbol: DNMT
  source: hgnc_prev_symbol
  hgnc_symbol: DNMT1
  entrez: '1786'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT5
  entrez: '23408'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC1
  entrez: '3065'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT2
  entrez: '22933'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: cut
  symbol: CUT
  source: hgnc_alias_symbol
  hgnc_symbol: CUX1
  entrez: '1523'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT1
  entrez: '23411'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC5
  entrez: '10014'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC11
  entrez: '79885'
- word: '"PTEN"""'
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: NRAS
  symbol: NRAS
  source: hgnc_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: KIT
  symbol: KIT
  source: hgnc_symbol
  hgnc_symbol: KIT
  entrez: '3815'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC10
  entrez: '83933'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT3
  entrez: '23410'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: AKT3
  symbol: AKT3
  source: hgnc_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: GNAQ/11
  symbol: GNAQ
  source: hgnc_symbol
  hgnc_symbol: GNAQ
  entrez: '2776'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC8
  entrez: '55869'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC3
  entrez: '8841'
- word: Bcl2
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC4
  entrez: '9759'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT7
  entrez: '51547'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC6
  entrez: '10013'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC7
  entrez: '51564'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC2
  entrez: '3066'
- word: Ac
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: SIRT6
  entrez: '51548'
- word: HDAC
  symbol: HDAC
  source: bioentities_symbol
  hgnc_symbol: HDAC9
  entrez: '9734'
chemicals:
- word: Lonafarnib
  source: MESH
  identifier: C115354
- word: Temsirolimus
  source: MESH
  identifier: C401859
- word: Nilotinib
  source: MESH
  identifier: C498826
- word: AZD6244
  source: MESH
  identifier: C517975
- word: RO4987655
  source: MESH
  identifier: C559138
- word: GSK2118436
  source: MESH
  identifier: C561627
- word: GDC-0973
  source: MESH
  identifier: C574276
- word: RO5126766
  source: MESH
  identifier: C577924
- word: AZD8330
  source: MESH
  identifier: C581956
- word: Rapamycin
  source: MESH
  identifier: D020123
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
---
